Overview
Target Audience
This symposium is directed primarily to medical oncologists, radiation oncologists, surgical oncologists, researchers and registered oncology nurses interested in new developments for treatment of various malignancies of cancer. No specific skill or knowledge other than a basic training in oncology is required for successful participation in this activity. Fellows, nurses and pharmacists are also invited to attend.
Statement of Need/Program Overview
This symposium is intended to provide comprehensive updates on biology, diagnosis, screening, and management of cancer. Paradigm shift in the treatment options of various malignancies of cancer will be discussed. This meeting will facilitate interaction among oncologists and researchers interested in development of novel therapeutics for treatment of cancer. In addition to multimodality therapy, adjuvant therapy and targeted therapies, this symposium will present data on pharmacogenomics and the role of individualized therapy of most promising emerging agents currently in development for the treatment of cancer. The format will include didactic lectures from known thought leaders, question and answer sessions, and ample opportunity for participant interaction with faculty. In-depth discussion of several chemotherapeutic agents at various stages of clinical development for multiple malignancies that target signaling pathways will be given significant focus. Emerging data from ongoing clinical research will be presented.
Accreditation Statement
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Postgraduate Institute for Medicine (PIM) and International Lung Cancer Network. PIM is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation
Postgraduate Institute for Medicine designates this educational activity for a maximum of 6.5 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Pharmacist Accreditation Statement
Postgraduate Institute for Medicine is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Credit Designation
Postgraduate Institute for Medicine designates this continuing education activity for 6.5 contact hours (0.65 CEUs) of the Accreditation Council for Pharmacy Education. (Universal Program Number – 809-999-07-144-L01-P)
Nursing Accreditation Statements
CNA/ANCC
This educational activity for 6.5 contact hours is provided by Postgraduate Institute for Medicine (PIM).
PIM is an approved provider of continuing nursing education by the Colorado Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.
California Board of Registered Nursing
Postgraduate Institute for Medicine is approved by the California Board of Registered Nursing, Provider Number 13485 for 6.5 contact hours.
A statement of credit will be issued only upon receipt of a completed activity evaluation form and will be mailed to you within three weeks.
Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by PIM for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.
Americans with Disabilities Act
Event staff will be glad to assist you with any special needs (ie, physical, dietary, etc). Please contact Roberta Granny prior to the live event at 717-531-1078.